Kenya - Inggris - Pharmacy and Poisons Board

brinzolamide usp - eye drops - brinzolamide… - brinzolamide

Kenya - Inggris - Pharmacy and Poisons Board

ajanta pharma limited ajanta house, charkop, kandivli (west) mumbai-400 - brinzolamide usp - eye drops - brinzolamide usp 1.0% w/v, benzalkonium chloride… - brinzolamide

Jepang - Inggris - すりの適正使用協議会 RAD-AR Council, Japan

senju pharmaceutical co.,ltd. - brinzolamide - white to faintly yellowish ophthalmic suspension

Jepang - Inggris - すりの適正使用協議会 RAD-AR Council, Japan

nitto medic co., ltd. - brinzolamide - white to faintly yellowish white ophthalmic suspension, (cap) white, (label) white, (body) clear

Amerika Serikat - Inggris - NLM (National Library of Medicine)

novartis pharmaceuticals corporation - brinzolamide (unii: 9451z89515) (brinzolamide - unii:9451z89515) - azopt is a carbonic anhydrase inhibitor indicated in the treatment of elevated intraocular pressure (iop) in patients with ocular hypertension or open-angle glaucoma. azopt is contraindicated in patients who are hypersensitive to any component of this product. risk summary there are no adequate and well-controlled studies in pregnant women to inform drug-associated risk. in reproductive toxicity studies, brinzolamide administered orally to rats induced fetal toxicity at 375 times the recommended human ophthalmic dose (rhod) based on mg/kg. in rabbits, no fetal toxicity was observed following oral administration (see data) . the background risk of major birth defects and miscarriage for the indicated population is unknown; however, in the u.s. general population, the estimated background risk of major birth defects is 2% to 4%, and of miscarriage is 15% to 20%, of clinically recognized pregnancies. data animal data embryo-fetal studies were conducted in pregnant rats administered 0, 2, 6, or 18 mg/kg/day brinz

Kenya - Inggris - Pharmacy and Poisons Board

novartis pharma ag litchtstrasse 35, 4056 basel, switzerland - brinzolamide, timolol maleate - eye drops, suspension - one ml of suspension contains 10 mg brinzolamide… - brinzolamide combinations

Kenya - Inggris - Pharmacy and Poisons Board

brinzolamide ophthalmic suspension usp 1%w/v - eye drops - each ml contains : brinzolamide usp… - brinzolamide

Uni Eropa - Inggris - EMA (European Medicines Agency)

novartis europharm limited - brinzolamide - glaucoma, open-angle; ocular hypertension - ophthalmologicals - azopt is indicated to decrease elevated intraocular pressure in:ocular hypertension;open-angle glaucomaas monotherapy in adult patients unresponsive to beta-blockers or in adult patients in whom beta-blockers are contraindicated, or as adjunctive therapy to beta-blockers or prostaglandin analogues.

Israel - Inggris - Ministry of Health

novartis israel ltd - brinzolamide; timolol as maleate - ophthalmic suspension - brinzolamide 10 mg/ml; timolol as maleate 5 mg/ml - timolol, combinations - timolol, combinations - decrease of intra-ocular pressure (iop) in adult patients with open-angle glaucoma or ocular hypertension for whom monotherapy provides insufficient iop reduction.

Selandia Baru - Inggris - Medsafe (Medicines Safety Authority)

novartis new zealand ltd - brinzolamide 10 mg/ml (a 2% overage is applied during manufacture);  ; timolol maleate 6.8 mg/ml equivalent to 5 mg/ml (0.5%) timolol as free base;   - eye drops, suspension - 1%/0.5% - active: brinzolamide 10 mg/ml (a 2% overage is applied during manufacture)   timolol maleate 6.8 mg/ml equivalent to 5 mg/ml (0.5%) timolol as free base   excipient: benzalkonium chloride carbomer disodium edetate hydrochloric acid mannitol purified water sodium chloride sodium hydroxide tyloxapol - azarga is indicated for the decrease of intraocular pressure (iop) in patients with open-angle glaucoma or ocular hypertension for whom monotherapy with either component provides insufficient iop reduction